Dr Reddy's Laboratories - 18 Year Stock Price History | RDY

Historical daily share price chart and data for Dr Reddy's Laboratories since 2001 adjusted for splits. The latest closing stock price for Dr Reddy's Laboratories as of May 17, 2019 is 39.38.
  • The all-time high Dr Reddy's Laboratories stock price is 66.33, which is 68.4% above the current share price.
  • The Dr Reddy's Laboratories 52-week high stock price is 42.76, which is 8.6% above the current share price.
  • The Dr Reddy's Laboratories 52-week low stock price is 28.24, which is 28.3% below the current share price.
  • The average Dr Reddy's Laboratories stock price for the last 52 weeks is 35.70.
Dr Reddy's Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 38.9945 37.5700 42.7600 35.7700 39.3800 4.46%
2018 33.6180 37.7583 39.1957 28.2419 37.7000 1.25%
2017 38.4308 44.7075 45.9472 29.8478 37.2329 -16.42%
2016 45.3363 44.6660 53.3952 40.3315 44.5501 -1.64%
2015 54.9614 48.7679 66.3288 42.6113 45.2922 -7.75%
2014 44.9451 38.9658 56.8261 37.3897 49.0988 23.76%
2013 35.3684 32.8266 39.8263 30.7527 39.6716 24.12%
2012 30.3414 28.7162 33.3926 26.1065 31.9625 14.03%
2011 31.8363 34.6510 36.4239 27.6875 28.0304 -18.30%
2010 28.4355 22.9165 38.7630 21.4981 34.3075 53.85%
2009 14.1316 9.3318 24.0679 6.7726 22.2994 148.96%
2008 12.1047 16.6010 16.6010 6.8823 8.9571 -45.69%
2007 14.7830 16.3467 16.7802 13.1044 16.4921 0.34%
2006 13.7682 9.8064 17.1477 9.8064 16.4370 69.17%
2005 8.1286 8.8134 9.8289 6.7576 9.7164 9.63%
2004 9.1009 14.3011 14.6609 6.7397 8.8626 -36.95%
2003 10.1112 8.6911 14.2745 7.8246 14.0568 64.50%
2002 8.4380 8.4640 10.4918 6.0829 8.5452 2.29%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $6.539B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $45.958B 8.37
Teva Pharmaceutical Industries (TEVA) Israel $11.826B 4.63
Mylan (MYL) United Kingdom $10.123B 4.42
Bausch Health Cos (BHC) Canada $8.818B 6.02
Supernus Pharmaceuticals (SUPN) United States $1.742B 17.41
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.230B 1.84
Amphastar Pharmaceuticals (AMPH) United States $1.032B 57.68
Homology Medicines (FIXX) United States $0.977B 0.00
CymaBay Therapeutics (CBAY) United States $0.867B 0.00
Voyager Therapeutics (VYGR) United States $0.816B 0.00
Akorn (AKRX) United States $0.527B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.393B 0.00
Assembly Biosciences (ASMB) United States $0.389B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.326B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.158B 0.00
Sol-Gel Technologies (SLGL) Israel $0.157B 0.00
Acasti Pharma (ACST) Canada $0.067B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Agile Therapeutics (AGRX) United States $0.062B 0.00
Teligent (TLGT) United States $0.046B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.013B 0.00